References
1. Korean society of Obstetrics and Gynecology. Obstetrics 2007. 4th edth ed. Seoul: Koonja Publishing; 193–197.
2. Reddy Uma M., Filly Roy A., Copel Joshua A.. Prenatal Imaging : Ultrasonography and Magnetic Resonance Imaging. American College of Obstetricans and Gynecologists. Obstet Gynecol 2008. 112145–157.
3. Ewigman BG, Crane JP, Frigoletto FD, LeFevre ML, Bain RP, McNellis D. Effect of prenatal ultrasound screening on perinatal outcome. N Engl J Med 1993. 329821–827.
5. Cicero S, Curcio P, Papageorghiou A, Soneck J, Nicolaides K. Absence of nasal bone in fetuses with trisomy 21 at 11~14 weeks of gestation: an observational study. Lancet 2001. 3581665–1667.
6. Cicero S, Spencer K, Avgidou K, Faiola S, Nicolaides K. Maternal serum biochemistry at 11-13+6 weeks in relation to the presence or absence of the fetal nasal bone on ultrasonography in chromosomally abnormal fetuses: an updated analysis of integrated ultrasound and biochemical screening. Prenat Diagn 2005. 25977–983.
7. Pitkin RM. Screening and detection of congenital malformation. Am J Obstet Gynecol 1991. 1641045–1048.
8. Campbell S, Pearce JM. The prenatal diagnosis of fetal structural anomalies by ultrasound. Clin Obstet Gynaecol 1983. 10475–506.
9. Hill LM, Breckle R, Gehrkng WC. Prenatal detection of congenital malformations by ultrasonography. Am J Obstet Gynecol 1985. 15144–50.
10. Manchester DK, Pretorius DH, Avery C, Manco-Johnson ML, Wiggins J, Meier PR, Clewell WH. Accuracy of ultrasound diagnoses in pregnancies complicated by suspected fetal anomalies. Prenat Diagn 1988. 8109–117.
11. Sabbagha RE, Sheikh Z, Tamura RK. Predictive value, sensitivity, and specificity of ultrasonic targeted imaging for fetal anomalies in gravid women at high risk for birth defects. Am J Obstet Gynecol 1985. 152822–827.
12. Filly RA, Cardorza JD, Goldstein RB, Barkovich AJ. Detection of fetal central nervous system anomalies: A practical level of effort for a routine sonogram. Radiology 1989. 172309–311.
13. Yeo L, Vintzileos AM. The use of genetic sonography to reduce the need for amniocentesis in women at high-risk for Down syndrome. Semin perinatol 2003. 27152–159.
14. Vintzileos AM, Egan JF. Adjusting the risk for trisomy 21 on the basis of second-trimester ultrasonography. Am J Obstet Gynecol 1995. 171639–1640.
15. Benacerraf BR, Nadel AS, Bromley B. Identification of second trimester fetuses with autosomal trisomy by use of a sonographic scoring index. Radiology 1994. 193135–140.
16. Nyberg DA, Luthy DA, Resta RG, Nyberg BC, Williams MA. Age-adjusted ultrasound risk assessment for fetal Down's syndrome during the second trimester: Description of the method and analysis of 142 cases. Ultrasound Obstet Gynecol 1998. 128–14.
17. Wax JR, Guilbert J, Mather J, Chen C, Royer D, Steinfeld JD, Ingardia CJ. Efficacy of community-based second trimester genetic ultrasonography in detecting the chromosomally abnormal fetus. J Ultrasound med 2000. 19689–694.
18. Gonçalves LF, Lee W, Espinoza J, Romero R. Three- and 4-dimensional ultrasound in obstetric practice: does it help? J Ultrasound Med 2005. 241599–1624.
19. Gonçalve LF, Nien JK, Espinoza J, Kusanovic JP, Lee W, Swope B, Soto E, Treadwell MC, Romero R. What does 2-dimensional imaging add to 3-and 4-dimensional obstetric ultrasonography? J Ultrasound Med 2006. 25691–699.
20. Levine D, Barens PD, Madsen JR, Li W, Edelman RR. Fetal central nervous system anomalies: MR imaging augments sonographic diagnosis. Radiology 1997. 204635–642.
21. Sponcer K, Spencer CE, Power M, Dawson C, Nicoladies KH. Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum bioche-mistry in a one-step clinic: a review three years prospec-tive experience. BJOG 2003. 110281–286.
22. Van Lith JM, Pratt JJ, Beekhuis JR, Mantingh A. Second-trimester maternal serum immunoreactive inhibin as a marker for fetal Down's syndrome. Prenat Diagn 1992. 12801–806.
23. Wald NJ, Densem JW, George L, Muttukrishna S, Knight PG. Prenatal screening for Down's syndrome using inhibin-A as a serum marker. Prenat Diagn 1996. 16143–153.
24. Malone Fergal D, Wald Nicholas J, Canick Jacob A, Ball Robert H, Nybergl David A. First- and second-trimester evaluation of risk (faster): trial principal results of the NICHD multicenter Down syndrome screening study. Am J of Obstet Gynecol 2003. 189S. 79.
25. Biggio JR, Morris TC, Owen J, Stringer JSA. An outcome analysis of five prenatal screening strategies for trisomy 21 in women younger than 35 years. Am J of Obstet Gynecol 2004. 190721–729.